Jhpiego’s program in Kenya, currently with nearly 200 staff, is one of Jhpiego’s largest and oldest. After an early focus on family planning and reproductive health, Jhpiego subsequently expanded its portfolio in Kenya by providing technical expertise in other areas such as maternal and child health, malaria, HIV/AIDS and tuberculosis.
Jhpiego’s programs that are currently active in Kenya include:
- APHIAplus Zone 4 (APHIAplus KAMILI), funded by the U.S. Agency for International Development (USAID)
- APHIAplus Zone 1 (APHIAplus Western Kenya), also funded by USAID, as a sub-grantee to PATH
- The USAID-funded Maternal and Child Survival Program
- The Kenya Urban Reproductive Health Initiative, funded by the Bill & Melinda Gates Foundation
- Brighter Future, a grant from Merck & Co.
- The Heart Program, funded by AstraZeneca
- Advance Family Planning (AFP2) Project
- Accelerating Scale-up of Implants, funded by the Bill & Melinda Gates Foundation
For a full description of these initiatives and Jhpiego’s partnerships in Kenya, click the link below.
For additional information, please visit the Jhpiego Kenya website at: http://www.jhpiego.org/kenya.